SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001019056-08-000438
Filing Date
2008-03-25
Accepted
2008-03-25 15:43:49
Documents
1
Group Members
APIS CAPITAL (QP), LPAPIS CAPITAL ADVISORS, LLCAPIS CAPITAL, LPAPIS GLOBAL DEEP VALUE OFFSHORE, LTDAPIS GLOBAL DEEP VALUE, LPAPIS OFFSHORE CAPITAL, LTD.DANIEL J. BARKERSTEVEN A. WERBER, JR.

Document Format Files

Seq Description Document Type Size
1 SC 13G bstc_13g.txt SC 13G 18790
  Complete submission text file 0001019056-08-000438.txt   20995
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Subject) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-79091 | Film No.: 08709374
SIC: 2834 Pharmaceutical Preparations

Mailing Address 53 FOREST AVENUE SUITE 103 OLD GREENWICH CT 06870
Business Address 53 FOREST AVENUE SUITE 103 OLD GREENWICH CT 06870 203-364-8809
APIS CAPITAL ADVISORS, LLC (Filed by) CIK: 0001386892 (see all company filings)

IRS No.: 200692626 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G